, ,
Presentations this author is a contributor to:
The safety and efficacy of eneboparatide, a parathyroid hormone 1 receptor agonist, in adults with chronic hypoparathyroidism: a phase 3, randomized, placebo-controlled study (CALYPSO) (#231)
9:20 AM
Maria Luisa Brandi
ESA - CaSR5 Joint Symposium | CaSR-5 Session 8: New therapies for hypoparathyroidism